Human platelets arise as subcellular fragments of megakaryocytes in bone marrow. The physiologic demand, presence of disease such as cancer, or drug effect
This work was supported in part by the University of Washington NIEHS sponsored Center for Ecogenetics and Environmental Health, Grant: NIEHS P30ES07033. References 1. Heimann R, Hellman S: Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin ...
Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA, 92037, USA Peter Teriete Corresponding author Correspondence to Martin Grimm. Additional information Competing interests The authors have no competing interests. Authors’ contributions MG and...
Combined Results for the Studies of Lung Cancer Screening With Computed Tomography Conducted at the Istituto Tumori (Milan, Italy), the Mayo Clinic (Rochester, Minn), and the Moffitt Cancer Center (Tampa, Fla). The left axis shows the actual and predicted numbers of individuals with different ...
(Khauv); Duke Eye Center, Duke University Hospital, Durham, North Carolina (Kheir, Materin); Sankara Nethralaya, Chennai, India (Khetan, Prom, N. Singh); Department of Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea (J. H. Kim); Ocular Oncology Service, ...
The understanding of the molecular pathobiology of acute myeloid leukemia (AML) has spurred the identification of therapeutic targets and the development of corresponding novel targeted therapies. Since 2017, twelve agents have been approved for the trea
The label-free digital pathology approach achieved 100% sensitivity and 93% specificity as compared to IHC with subsequent fragment length analysis (FLA). Table 1 The table shows the IHC, PCR and IR imaging results for the 60 independent validation patients. Full size table Results Label-free ...
“Many people don’t want to share this kind of news because they don’t want to be ‘outed’ or seen as ‘the cancer patient’ and pitied,” says Jill Kaplan, an oncology social worker at Memorial Sloan-Kettering Cancer Center in Basking Ridge, N.J. “Others feel out of control or...
most trials had small sample sizes and were not multi-center; only one study investigated the mechanisms of action of the studied CHD; and the active components of CHDs were not explored. To promote international recognition of CHDs, rigorously designed studies on clinical outcomes, mechanisms of ...
Legha SS, Ring S, Eton O, Bedikian A, Plager C, Papadopoulos N. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience. Cancer J Sci Am 1997; 3 (Suppl. 1): S9–15. ...